VEON confirms revised timing for effectiveness of ratio change under its American Depositary Receipt (ADR) program

07/03/2023

07 Mar 2023

VEON confirms revised timing for effectiveness of ratio change under its American Depositary Receipt ( ADR ) program Amsterdam, Netherlands, 7 March 2023 16:30 CET: VEON Ltd. (NASDAQ, Euronext Amsterdam: VEON) ( VEON or the Company ), a global digital operator that provides converged connectivity and online services, today provides an update on the timing of the ratio change under the Company's ADR program, previously announced on 6 February 2023 and originally planned to become effective on 6 March 2023 (the Ratio Change ). As announced on 6 March 2023, the Company was informed late afternoon on Friday, 3 March 2023 by BNY Mellon that the ratio change effectiveness had been postponed as The Depository Trust & Clearing Corporation ( DTCC ) was not prepared to make the new CUSIP reflecting the new ratio available on Monday, 6 March 2023 as scheduled. DTCC has now confirmed the availability of the new CUSIP, and the effective date of the Ratio Change (the Effective Date ) is now confirmed as 8 March 2023.

As previously announced with respect to the Ratio Change, as of the Effective Date, record holders who directly hold ADRs will be required to exchange their existing ADRs for new ADRs on the basis of one (1) new ADR for every twenty-five (25) existing ADRs surrendered. The Depositary will contact ADR holders and arrange for the exchange of their existing ADRs for new ADRs. American Depositary Share ( ADS ) beneficial holders who hold through an ADR holder intermediary need not take any action in connection with the Ratio Change.

For ADS holders, the Ratio Change will have the same effect as a one for twenty five reverse ADS split. No new VEON common shares will be issued in connection with the Ratio Change and the ADSs will continue to be traded on The Nasdaq Capital Market under the symbol VEON.

As a result of the Ratio Change, the trading price of the Company's ADSs is expected to automatically increase proportionally, but the Company can give no assurance that the ADS trading price following the Ratio Change will be at least equal to the ADS trading price before the Ratio Change multiplied by the new 25:1 ratio. As VEON announced previously on 5 October 2022, the Listing Qualifications Department of The Nasdaq Market granted VEON an additional grace period through 3 April 2023 to regain compliance with the minimum bid price requirement set forth in Nasdaq's Listing Rule 5550(a)(2) (the Minimum Bid Price ). While the Ratio Change is intended to bring the bid price of the Company's ADSs into compliance with the Minimum Bid Price, the Company can give no assurance that the Ratio Change will be effective in achieving this goal.

The Company's original announcement with respect to the ratio change can be found on the Company's website at this address:

www.veon.com/newsroom/press-releases/veon-announces-ratio-change-under-its-american-depositary-receipt-adr-program

About VEON

VEON is a global digital operator that currently provides converged connectivity and online services to over 200 million customers in seven dynamic markets.We are transforming people's lives, empowering individuals, creating opportunities for greater digital inclusion and driving economic growth across countries that are home to more than 8% of the world's population. Headquartered in Amsterdam, VEON is listed on NASDAQ and Euronext.

For more information visit: www.veon.com.

Important Notice

Elements of this press release contain or may contain inside information as defined under the Market Abuse Regulation (EU) No. 596/2014.

Disclaimer

This release contains forward-looking statements, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, expectations regarding the ADR ratio change. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws and except as set forth above, any forward-looking statement to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Contact information

VEON

Group Director Investor Relations

Nik Kershaw

ir@veon.com

This website stores cookies on your computer. These cookies are used to improve vour website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy

We wont track your information when you visit our site. But in order to comply with your preferences, well have to use just one tiny cookie so that youre not asked to make this choice again.

AcceptDecline

LINK:	https://www.veon.com/media/media-releases/2023/veon-confirms-revised-t...
	See more stories from vimpel

VEON confirms revised timing for effectiveness of ratio change under its American Depositary Receipt (ADR) program

More from VimpelCom

08/05/2025

07/05/2025

02/05/2025

25/04/2025

14/04/2025

08/04/2025

31/03/2025

27/03/2025

26/03/2025

21/03/2025

20/03/2025

20/03/2025

20/03/2025

19/03/2025

18/03/2025

17/03/2025

12/03/2025

06/03/2025

05/03/2025

04/03/2025

26/02/2025

14/02/2025

12/02/2025

30/01/2025

16/01/2025

13/01/2025

09/01/2025

30/12/2024

19/12/2024

13/12/2024

12/12/2024

11/12/2024

09/12/2024

05/12/2024

03/12/2024

02/12/2024

29/11/2024

25/11/2024

21/11/2024

21/11/2024

20/11/2024

19/11/2024

15/11/2024

14/11/2024

13/11/2024

12/11/2024

11/11/2024

08/11/2024

07/11/2024

05/11/2024